nach oben

Digestive Diseases and Sciences

Erschienen in:

01.04.2011 | Review

Unusual Case of Small Cell Gastric Carcinoma: Case Report and Literature Review

verfasst von: David Richards, Daniel Davis, Peisha Yan, Sushovan Guha

Erschienen in: Digestive Diseases and Sciences | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Small cell carcinomas are among the most aggressive, poorly differentiated, and highly malignant of the neuroendocrine tumors (NETs). Of which, small cell gastric carcinoma is a rare small cell neuroendocrine tumor. The purpose of our study was to present this case and perform a comprehensive literature review.

Methods and Results

We review a case of small cell gastric carcinoma that is particularly unusual in that it occurred in a woman from the US when the majority of cases of small cell gastric carcinoma have been reported in men from East Asia, and more specifically, from Japan. The diagnosis was made after endoscopy revealed a large ulcerated mass in the gastric cardia of Borrmann type 3. Biopsies revealed multiple small basophilic cells underlying the squamous epithelium of the esophagus and cardiac mucosa, indicating the presence of a tumor at the gastroesophageal junction. Immunostaining established the diagnosis with positive stains for chromogranin, synaptophysin, and CD56. Our patient is being treated with chemotherapy, but many different treatment regimens have been tried for small cell gastric carcinoma with variable success.

Conclusions

Overall prognosis for small cell gastric carcinoma is dismal. Neuroendocrine tumors in general have variable clinical behaviors and prognosis is dependent on the neuroendocrine tumor type. The adoption of a standardized classification system for neuroendocrine tumors could improve the recognition of infrequently encountered neuroendocrine tumors like small cell gastric carcinoma and will enhance strategies for treatment and thus improve prognosis for patients with these rare and aggressive tumors.

Bajetta E, Catena L, Procopio G, Bichisao E, et al. Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Onc. 2005;16:1374–1380.CrossRef

Wick MR. Neuroendocrine neoplasia: current concepts. Am J Clin Pathol. 2000;113:331–335.PubMedCrossRef

Chejfec G, Gould VE. Malignant gastric neuroendocrinomas. Ultrastructural and biochemical characterization of their secretory activity. Hum Pathol. 1977;8:433–440.PubMedCrossRef

Ibrahim NB, Briggs JC, Corbishley CM. Extrapulmonary oat cell carcinoma. Cancer. 1984;54:1645–1661.PubMedCrossRef

Fer MF, Levenson Jr RM, Cohen MH, Greco FA. Extrapulmonary small cell carcinoma. In: Greco FA, Oldham RK, Bunn PA, eds. Small Cell Lung Cancer. New York: Grune & Stratton; 1981:301–326.

Iwamuro M, Tanaka S, Bessho A, Takahashi H, et al. Two cases of primary small cell carcinoma of the stomach. Acta Med Okayama. 2009;63:293–298.PubMed

Kusayanagi S, Konishi K, Miyasaka N, Sasaki K, et al. Primary small cell carcinoma of the stomach. J Gastroenterol Hepatol. 2003;18:743–747.PubMedCrossRef

Tanemura H, Ohshita H, Kanno A, Kusakabe M, et al. A patient with small-cell carcinoma of the stomach with long survival after percutaneous microwave coagulating therapy (PMCT) for liver metastasis. Int J Clin Oncol. 2002;7:128–132.PubMed

Brenner B, Tang LH, Klimstra DS, Kelsen DP. Small-cell carcinomas of the gastrointestinal tract: a review. J Clin Oncol. 2004;22:2730–2739.PubMedCrossRef

10.

Shpaner A, Yusuf TE. Primary gastric small-cell neuroendocrine carcinoma. Endoscopy. 2007;39(Suppl 1):E310–E311.PubMedCrossRef

11.

Takeuchi H, Futamata K, Maeshima A, Hirose S, et al. A case of primary gastric small cell carcinoma with a rare pattern of lymph node metastasis. Int J Gastrointest Cancer. 2005;36:99–104.PubMedCrossRef

12.

Arai KMD, Matsuda MMD. Gastric small-cell carcinoma in Japan: a case report and review of the literature. Am J Clin Oncol. 1998;21(5):458–461.CrossRef

13.

Badger SA, Lee J, Vazir H, Diamond T, Panesar KJ. Extra-pulmonary oat cell carcinoma: report of two cases. Ulster Med J. 2005;74:63–65.PubMed

14.

Bravo E, Estraviz B, Landaluce A, Sarabia S. Small (oat)-cell carcinoma of the gastrointestinal tract. Cir Esp. 2008;83:153–155.PubMedCrossRef

15.

Bugalho P, Chorao M, Fontoura P. Miliary brain metastases from primary gastric small cell carcinoma: illustrating the seed and soil hypothesis. J Neurooncol. 2005;73:53–56.PubMed

16.

Chaudhary UB, Taksey JD, Johnson RD, Lewin DN. Small-cell cancers, and an unusual reaction to chemotherapy: case 3. Small-cell carcinoma of the stomach. J Clin Oncol. 2003;21:2441–2442.PubMedCrossRef

17.

Chetty R, Weinreb I. Gastric neuroendocrine carcinoma arising from heterotopic pancreatic tissue. J Clin Pathol. 2004;57:314–317.PubMedCrossRef

18.

Cioppa T, Marrelli D, Neri A, Caruso S, et al. A case of small-cell gastric carcinoma with an adenocarcinoma component and hepatic metastases: treatment with systemic and intra-hepatic chemotherapy. Eur J Cancer Care (Engl). 2007;16:453–457.CrossRef

19.

Hamano R, Hirao T, Tokuoka M, Masuzawa T, Shibata K, Kobayashi T. A case report of gastric small cell carcinoma with long survival time by adjuvant chemotherapy—reports of chemotherapy regimens for gastric small cell carcinoma. Gan To Kagaku Ryoho. 2007;34:609–613.PubMed

20.

Han B, Mori I, Wang X, Nakamura M, Nakamura Y, Kakudo K. Combined small-cell carcinoma of the stomach: p53 and K-ras gene mutational analysis supports a monoclonal origin of three histological components. Int J Exp Pathol. 2005;86:213–218.PubMedCrossRef

21.

Hasegawa S, Yamamoto Y, Ishiwa N, Yoshikawa T, et al. A case of small cell carcinoma of the stomach. Gan To Kagaku Ryoho. 2003;30:999–1002.PubMed

22.

Hirano Y, Hara T, Nozawa H, Oyama K, et al. Combined choriocarcinoma, neuroendocrine cell carcinoma and tubular adenocarcinoma in the stomach. World J Gastroenterol. 2008;14:3269–3272.PubMedCrossRef

23.

Hosoya Y, Nagai H, Koinuma K, Yasuda Y, Kaneko Y, Saito K. A case of aggressive neuroendocrine carcinoma of the stomach. Gastric Cancer. 2003;6:55–59.PubMedCrossRef

24.

Hussein AM, Otrakji CL, Hussein BT. Small cell carcinoma of the stomach. Case report and review of the literature. Dig Dis Sci. 1990;35:513–518.PubMedCrossRef

25.

Kato T, Sato K, Tamahashi N, Yano H, Masuoka HO. A case of small cell carcinoma of the stomach. Gan To Kagaku Ryoho. 2005;32:1473–1475.PubMed

26.

Koide N, Suzuki A, Saito H, Sato T, et al. Gastric small cell carcinoma successfully treated by surgery and postoperative chemotherapy consisting of cisplatin and S-1: report of a case. Surg Today. 2007;37:989–994.PubMedCrossRef

27.

Kuo SC, Chao Y, Luo JC, Lee KC, et al. Primary small cell carcinoma of the stomach successfully treated with cisplatin and etoposide. J Chin Med Assoc. 2009;72:598–602.PubMedCrossRef

28.

Nakamura Y, Otani S, Otaka M, Shimada T, et al. Gastric small cell carcinoma with marked response to neoadjuvant chemotherapy. Int J Clin Oncol. 2005;10:348–352.PubMedCrossRef

29.

Namikawa T, Kobayashi M, Okabayashi T, Ozaki S, et al. Primary gastric small cell carcinoma: report of a case and review of the literature. Med Mol Morphol. 2005;38:256–261.PubMedCrossRef

30.

O’Byrne KJ, Cherukuri AK, Khan MI, Farrell RJ, et al. Extrapulmonary small cell gastric carcinoma. A case report and review of the literature. Acta Oncol. 1997;36:78–80.PubMedCrossRef

31.

Saeki H, Anegawa G, Masuda T, Ohta R, et al. A case of inoperable gastric small cell carcinoma effectively treated by chemotherapy and radiotherapy. Gan To Kagaku Ryoho. 2006;33:977–979.PubMed

32.

Shimada M, Iwase H, Iyo T, Nakarai K, et al. A case of complete response in a primary lesion treated by combined chemotherapy of TS-1 and CDDP for small cell carcinoma of the stomach with liver metastasis. Gan To Kagaku Ryoho. 2004;31:593–596.PubMed

33.

Takaku H, Oka K, Naoi Y, Santoh N, Setsu Y, Mori N. Primary advanced gastric small cell carcinoma: a case report and review of the literature. Am J Gastroenterol. 1999;94:1402–1404.PubMed

34.

Yamaguchi T, Imamura Y, Nakayama K, Kawada T, Yamamoto T, Fukuda M. Paranuclear blue inclusions of small cell carcinoma of the stomach: report of a case with cytologic presentation in peritoneal washings. Acta Cytol. 2005;49:207–212.PubMedCrossRef

35.

Yamazaki K. A gastric carcinosarcoma with neuroendocrine cell differentiation and undifferentiated spindle-shaped sarcoma component possibly progressing from the conventional tubular adenocarcinoma; an immunohistochemical and ultrastructural study. Virchows Arch. 2003;442:77–81.PubMed

36.

Yata Y, Nakayama Y, Takahara T, Yamazaki K, et al. A case of small cell gastric carcinoma with an adenocarcinoma component operated curatively. Acta Med Okayama. 2004;58:275–278.PubMed

37.

Tulchinsky M. F-18 FDG PET/CT in primary gastric small cell carcinoma. Clin Nucl Med. 2009;34:44–47.PubMedCrossRef

38.

Van Der Gaast A, Verwey J, Prins E, Splinter TA. Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas. Cancer. 1990;65:422–424.CrossRef

39.

Brouland JP, Manivet P, Brocheriou-Spelle I, Wassef M, et al. Histological, immunohistochemical, ultrastructural and biochemical study of human gastric composite tumor: expression of the serotonin-2B receptor by the neuroendocrine component. Endocr Pathol. 2001;12:77–86.PubMedCrossRef

40.

Matsui K, Jin XM, Kitagawa M, Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med. 1998;122:1010–1017.PubMed

41.

Fenoglio-Preiser CM. Gastrointestinal neuroendocrine/neuroectodermal tumors. Am J Clin Pathol. 2001;115:S79–S93.PubMed

42.

Watanabe N, Kato H, Shimizu M, Murakami J, et al. F-18 FDG PET imaging in gastric neuroendocrine carcinoma. Clin Nucl Med. 2006;31:345–346.PubMedCrossRef

43.

Schindl M, Kaserer K, Niederle B. Treatment of gastric neuroendocrine tumors: the necessity of a type-adapted treatment. Arch Surg. 2001;136:49–54.PubMedCrossRef

44.

Hosokawa A, Shimada Y, Shirao K, Matsumura Y, et al. Long-term survivor of gastric small cell carcinoma. Hepatogastroenterology. 2004;51:1567–1570.PubMed

Titel: Unusual Case of Small Cell Gastric Carcinoma: Case Report and Literature Review
verfasst von: David Richards
Daniel Davis
Peisha Yan
Sushovan Guha
Publikationsdatum: 01.04.2011
Verlag: Springer US
Erschienen in: Digestive Diseases and Sciences / Ausgabe 4/2011
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI: https://doi.org/10.1007/s10620-010-1404-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Background

Methods and Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2011

The Expression of PTHLH in Human Gastric Mucosa Enterochromaffin-Like Cells

Role of a Short-Term Stent-Trial in a Patient with Biliary Stricture and Portal Hypertensive Biliopathy: Long-Term Outcome Result

Does Grading the Severity of Gastroparesis Based on Scintigraphic Gastric Emptying Predict the Treatment Outcome of Patients with Gastroparesis?

“War and Peace” with Barrett’s Esophagus

Expression and Prognostic Significance of CD151, c-Met, and Integrin alpha3/alpha6 in Pancreatic Ductal Adenocarcinoma